A novel vaccinia virus with dual oncolytic and anti-angiogenic therapeutic effects against triple-negative breast cancer

导出原文传递

翻译打印收藏纠错

作者： Gholami,S. ^[1] ; Marano,A. ^[2] ; Chen,N.G. ^[3] ; Aguilar,R.J. ^[4] ; Frentzen,A. ^[5] ; Chen,C.-H. ^[6] ; Lou,E. ; Fujisawa,S. ; Eveno,C. ; Belin,L. ; Zanzonico,P. ; Szalay,A. ; Fong,Y.

作者单位： Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of ^[1] Genelux Corporation, San Diego Science CenterSan Diego, CA, United States, Department of Radiation ^[2] Departments of Medical Physics and Radiology, Memorial Sloan-Kettering Cancer CenterNew York, NY ^[3] Genelux Corporation, San Diego Science CenterSan Diego, CA, United States ^[4] Molecular Cytology Core Facility, Memorial Sloan-Kettering Cancer CenterNew York, NY, United States ^[5] Department of Surgery, Memorial Sloan-Kettering Cancer CenterNew York, NY, United States ^[6]

关键词 Anti-angiogenesis GLV-1h164 Oncolytic viral therapy Triple-negative breast cancer Vaccinia virus

发布时间 2015-02-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交